THBS2 and hepatocellular carcinoma: In this study, we first examined the serum TSP-2 levels at the end of DAA treatment in 524 CHC patients in the derivation cohort and found that the serum TSP-2 levels were significantly higher in the patients who later developed HCC than in those who did not.